← Eichor
Study identifier: NCT06808334 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

CLAiR Pivotal Study

Condition: No Condition  ·  Sponsor: Toku Eyes Ltd

PhaseN/A
Planned participants942
Who can joinAll sexes, 40 Years to 75 Years
Healthy volunteersYes

About this study

This is a multi-site, observational clinical study to validate the performance of the CLAiR AI software in identifying elevated atherosclerotic cardiovascular disease (ASCVD) risk from retinal (eye) images obtained from two different retinal image camera models.

This description comes directly from the study's public registry record.

Talk to the study team

Yariv Levinson  ·  (240) 442 2479  ·  yariv.levin@tokueyes.com

Always discuss trial participation with your own doctor first.

Locations (1)

Diabetes and Endocrine Associates of Stark CountyCanton, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06808334